Euglycemic diabetic ketoacidosis in type 2-diabetes mellitus treated with SGLT2 inhibitors - a report on two cases

Euglycemic diabetic ketoacidosis in type 2-diabetes mellitus treated with SGLT2 inhibitors - a report on two cases

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new second-line medication in the management of hyperglycemia in type 2 diabetes. These drugs can be associated with the development of diabetic ketoacidosis (DKA) with normal or moderately increased blood glucose levels. This is a life-threat...

Full description

Bibliographic Details
Main Authors: Antonio Burgio, Maurizio Alletto, Salvatore Amico, Umberto Castiglione, Giovanni Fulco, Concetta Groppuso, Gianfranco Gruttadauria, Susanna Salvaggio, Aulo Di Grande, Federico Vancheri
Format: Article
Language:English
Published: PAGEPress Publications 2018-11-01
Series:Italian Journal of Medicine
Subjects:
Euglycaemic diabetic ketoacidosis
SGTL2
diabetes mellitus
diabetic ketoacidosis.
Online Access:https://italjmed.org/index.php/ijm/article/view/1061

Internet

https://italjmed.org/index.php/ijm/article/view/1061

Similar Items